Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
The Journal of Urology|October 23, 2012
Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trialsSujata Patil, Judith Manola, Paul Elson, et al.
Breast Cancer Research and Treatment|April 28, 2012
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationYong Hannah Wen, Alice Ho, Sujata Patil, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
American Journal of Surgery|August 31, 2010
The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancerMatthew Pugliese, Michelle Stempel, Sujata Patil, et al.
Clinical Genitourinary Cancer|May 27, 2008
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinomaDarren R Feldman, G Varuni Kondagunta, Lawrence Schwartz, et al.
Annals of Surgical Oncology|August 13, 2015
Breast-Conserving Surgery in Bilateral Breast CancerJulie A O'Brien, Alice Ho, G Paul Wright, et al.
Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.
Investigational New Drugs|June 24, 2009
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumorsDarren R Feldman, Stefan Turkula, Michelle S Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Breast Cancer Research and Treatment|October 22, 2013
Is there a role for routine screening MRI in women with LCIS?Tari A King, Shirin Muhsen, Sujata Patil, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
The Journal of Urology|October 23, 2012
Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trialsSujata Patil, Judith Manola, Paul Elson, et al.
Breast Cancer Research and Treatment|April 28, 2012
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationYong Hannah Wen, Alice Ho, Sujata Patil, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
American Journal of Surgery|August 31, 2010
The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancerMatthew Pugliese, Michelle Stempel, Sujata Patil, et al.
Clinical Genitourinary Cancer|May 27, 2008
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinomaDarren R Feldman, G Varuni Kondagunta, Lawrence Schwartz, et al.
Annals of Surgical Oncology|August 13, 2015
Breast-Conserving Surgery in Bilateral Breast CancerJulie A O'Brien, Alice Ho, G Paul Wright, et al.
Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.
Investigational New Drugs|June 24, 2009
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumorsDarren R Feldman, Stefan Turkula, Michelle S Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Breast Cancer Research and Treatment|October 22, 2013
Is there a role for routine screening MRI in women with LCIS?Tari A King, Shirin Muhsen, Sujata Patil, et al.
Pageof 23